J Med Microbiol International Journal of Systematic and Evolutionary Microbiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.
Agricola
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.
J Med Microbiol 55 (2006), 677-688; DOI: 10.1099/jmm.0.46461-0
© 2006 Society for General Microbiology
ISSN 1473-5644

Use of suppression subtractive hybridization to examine the accessory genome of the Liverpool cystic fibrosis epidemic strain of Pseudomonas aeruginosa

Catherine H. M. Smart1, Martin J. Walshaw2, C. Anthony Hart1 and Craig Winstanley1

1 Division of Medical Microbiology and Genitourinary Medicine, University of Liverpool, Liverpool L69 3GA, UK

2 Regional Adult Cystic Fibrosis Unit, Cardiothoracic Centre, Liverpool L14 3PE, UK

Correspondence
Craig Winstanley
C.Winstanley{at}liv.ac.uk

Received 9 December 2005
Accepted 20 February 2006


The Liverpool epidemic strain (LES) of Pseudomonas aeruginosa has been highly successful at colonizing cystic fibrosis (CF) patients throughout the UK, has replaced previously established strains in CF patients, has caused infections of non-CF parents of CF patients, and can cause greater morbidity in CF than other strains of P. aeruginosa. Using suppression subtractive hybridization (SSH) to identify strain-specific sequences, a diagnostic test for the LES based on PCR amplification of SSH sequence PS21 had previously been developed. In this study, the SSH sequence database of LES was substantially increased, using both extension of previous sequences and new rounds of subtraction. Of 92 SSH sequences identified as present in the LES but absent from strain PAO1, 25 were assessed for prevalence amongst a strain panel consisting mainly of LES and non-LES CF isolates. Preliminary analysis of genome sequence data indicated that all SSH sequences that were LES specific or found only rarely in other strains of P. aeruginosa were present on one of three contigs. All of the SSH sequences screened were either unstable amongst LES isolates or were not completely LES specific. Rare false positives were found with the PS21 test. The authors suggest that a second PCR assay designed to detect SSH sequence LESF9 can be used to confirm the identity of the most prevalent CF epidemic lineage in the UK.


Abbreviations: CF, cystic fibrosis; FHA, filamentous haemagglutinin; LES, Liverpool epidemic strain; SSH, suppression subtractive hybridization.


    INTRODUCTION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Cystic fibrosis (CF) is the most common life-threatening inherited disease amongst Caucasians. Although patient management and infection control policies have increased life expectancy to approximately 31 years (www.cftrust.org.uk), most patients eventually succumb to morbidity and mortality due primarily to chronic bacterial infections of the lung. The most common and important CF pathogen is Pseudomonas aeruginosa, which establishes chronic, long-term pulmonary infections associated with a biofilm lifestyle and the production of alginate, leading to a mucoid phenotype. Once established, P. aeruginosa infections cannot be eradicated, and CF patients suffer decline in lung function associated with periodic exacerbations. Until a decade ago, it was generally accepted that CF patients acquired P. aeruginosa infections individually from the environment, and thus carried strains unrelated to those of other patients. In 1996, Cheng et al. (1996) reported the spread of a drug-resistant strain of P. aeruginosa (named the Liverpool epidemic strain, LES) amongst patients in a children's CF centre in Liverpool, UK. Subsequently other P. aeruginosa CF ‘epidemic’ strains have been reported in Australia (Armstrong et al., 2003; O'Carroll et al., 2004), Manchester, UK (Jones et al., 2001), and the Midlands, UK (Scott & Pitt, 2004; Chambers et al., 2005), raising serious questions about whether segregation strategies might be required to counter transmission. Recent analysis of post-2000 patient samples has identified the LES in 79 % of 80 P. aeruginosa-colonized CF patients in the Liverpool adult CF centre, confirming the spread and longevity of LES infections (Panagea et al., 2003). In addition to its transmissibility, the LES has been shown to replace previously established strains of P. aeruginosa (superinfection; McCallum et al., 2001) and has infected both non-CF parents of a CF patient, causing significant morbidity (McCallum et al., 2002). Furthermore, there is evidence for greater morbidity amongst CF patients colonized with the LES compared to those carrying non-epidemic strains of P. aeruginosa (Al Aloul et al., 2004). Recently, we have demonstrated that some isolates of the LES express an unusual ‘hypervirulence’ phenotype characterized by early expression and overexpression of quorum-sensing-regulated virulence genes (Salunkhe et al., 2005).

A survey of 31 CF centres in England and Wales, in which over 1200 isolates of P. aeruginosa were analysed, has identified the LES as the most common clone, being present in 48 % of CF centres and accounting for 11 % of the isolates (Scott & Pitt, 2004). The strain has also been identified amongst CF isolates in Scotland (Edenborough et al., 2004). The antibiotic susceptibilities of LES isolates vary widely (Panagea et al., 2003; Salunkhe et al., 2005), and the ‘gold-standard’ typing method, macrorestriction analysis using PFGE, is time-consuming and requires specialist equipment. A PCR-based diagnostic test for the LES (Parsons et al., 2002) has been evaluated in studies with a large number of CF isolates and found to be 100 % in concordance with identification using PFGE (Panagea et al., 2003; Scott & Pitt, 2004). Furthermore, the test has successfully been applied directly to patient sputum samples (Panagea et al., 2003). The PCR assay is used to amplify one of a number of sequences (named PS21) identified previously using suppression subtractive hybridization (SSH), a technique that enables the identification of sequences present in one strain but absent from another (Parsons et al., 2002; Winstanley, 2002). However, more recently, we and others have identified a small number of non-LES isolates that are positive using the diagnostic test (Lewis et al., 2005; F. W. Scott and T. L. Pitt, unpublished data).

P. aeruginosa contains a core genome that possesses a highly conserved backbone comprising the vast majority of the genome and including most of the recognized virulence factors (Ernst et al., 2003; Wolfgang et al., 2003), and an accessory genome (or mobilome) that includes mobile genetic elements and genomic islands (Larbig et al., 2002; Spencer et al., 2003). The accessory genome of the LES is likely to contain not only strain-specific sequences that could be targeted for identification, but also novel genomic islands that may contribute to the extra abilities possessed by this strain. A genome sequence project to identify all such regions has been initiated in collaboration with the Sanger Centre, Hinxton, UK (http://www.sanger.ac.uk/Projects/P_aeruginosa/).

In this study, we report the further characterization of PS21 and two other previously identified subtracted sequences, and report the results of further SSH to identify a much larger number of sequences present in the accessory genome of LES. By using preliminary data from the genome sequence project we further group many of these sequences into islands or gene clusters. Finally, we combine the data to report the development of improved PCR assays to identify the most common epidemic strain of P. aeruginosa in the UK CF community.


    METHODS
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Bacterial strains. Isolate LES400 was obtained from a CF patient and has been used previously for SSH (Parsons et al., 2002). The reference strain (driver) for SSH experiments was strain PAO1, for which the entire genome sequence is known (Stover et al., 2000). For prevalence studies, we had several categories of strain panels (Table 1Go). Twenty-two isolates of the LES, 12 isolates of the Midlands1 epidemic strain, and 11 isolates of the Manchester epidemic strain were taken, mainly from isolates obtained during the survey of CF isolates in England and Wales (Scott & Pitt, 2004). Sixteen genetically distinct non-LES isolates from adult patients in Liverpool were included from our previous SSH study (Parsons et al., 2002). In addition, we obtained 43 more recent, uncharacterized, non-LES isolates (PS21 negative) from the Liverpool adult CF unit, and 32 uncharacterized non-LES CF isolates from a neighbouring adult CF unit at Clatterbridge Hospital, Merseyside, UK. We also screened representative isolates of clone C (Römling et al., 1994) and strain PA14 (Rahme et al., 1995). In addition, four PS21 false-positive (non-LES) isolates were also screened (gifts of Ty Pitt and Fiona Scott, Health Protection Agency, UK).


View this table:
[in this window]
[in a new window]
 
Table 1. Strains used in this study

 
GenomeWalker entension of sequences. Previously identified subtracted sequences [PS21, PSA and PS54 (Parsons et al., 2002)] were extended using the PCR-based GenomeWalker kit (Clontech), following the manufacturer's instructions.

Construction and screening of subtraction libraries. Genomic DNA was isolated from P. aeruginosa LES400 and strain PAO1 as described previously (Winstanley & Hart, 2000). SSH was carried out using the CLONTECH PCR-Select Bacterial Genome Subtraction kit (Clontech) as recommended by the supplier, but with a hybridization temperature of 73 °C. In the hybridizations, DNA from the LES was used as the tester and DNA from strain PAO1 was used as the driver. PCR amplicons obtained following SSH were cloned into pGEM-T (Invitrogen). The subtraction library of RsaI fragments thus constructed was screened by sequencing of plasmid DNA extracted from individual clones (Lark Technologies) using M13 forward and reverse vector primers. BLAST searches at the P. aeruginosa PAO1 genome project web site (http://www.pseudomonas.com) were used to determine the presence or absence of sequences in the PAO1 genome. Tester-specific sequences were further analysed using BLASTN and BLASTX searches of the general database using the site http://www.ncbi.nlm.nih.gov. The relative positions of sequences in the LES genome were determined by BLASTN searching the preliminary data available at the site http://www.sanger.ac.uk/cgi-bin/blast/submitblast/p_aeruginosa. Subsequent analysis of downloaded sequence data was carried out using the program ARTEMIS.

PCR amplification screening of strains. Oligonucleotide primers (Sigma-Genosys) used in PCR assays are listed in Table 2Go along with the annealing temperatures used. DNA for PCR amplification was prepared by making a suspension of a few colonies in 200 µl 5 % Chelex-100 (Sigma) solution. After vigorous mixing, the suspension was boiled for 5–10 min. Following centrifugation, 150 µl of supernatant containing the DNA was removed and stored at –20 °C. Typically, 1 µl of this DNA was used directly in 25 µl volumes containing 1.25 units Taq DNA polymerase (Promega), 1x TaqMaster (Helena Biosciences), 300 nM each primer, 1x Taq buffer, 2.5 mM MgCl2 and 100 µM nucleotides (dATP, dCTP, dGTP, dTTP). Amplifications were carried out in an Eppendorf MasterCycler thermal cycler for 30 cycles consisting of 95 °C (1 min), annealing temperature (1 min) and 72 °C (2 min), with an additional extension time at 72 °C (10 min) following completion of the 30 cycles.


View this table:
[in this window]
[in a new window]
 
Table 2. Oligonucleotide primers used in this study

 
PFGE. PFGE of SpeI-digested genomic DNA was carried out using 1 % (w/v) agarose gels and interpreted according to the protocol of Tenover et al. (1995).


    RESULTS AND DISCUSSION
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Extending PS21 and other subtracted sequences

Using the GenomeWalker system, the PS21 sequence (previously 400 bp) was extended upstream and downstream to 1256 bp. Of the extended sequence, 750 bp shared significant similarity with the C termini of merA (mercuric reductase) genes/proteins in the database. The best predicted protein match was with a Streptomyces sp. MerA (Table 3Go). All of the best matches were to proteins from Gram-positive bacteria. The PS21 diagnostic sequence itself overlapped with 50 bp of the predicted merA gene. PS54, another sequence identified previously as unique to the LES (Parsons et al., 2002), was extended from 425 to 860 bp. A predicted protein derived from nucleotide positions 131–667 contained a conserved domain found in N-acetyltransferases (Table 3Go).


View this table:
[in this window]
[in a new window]
 
Table 3. Summary of LES SSH

SSH sequences sharing less than 90 % nucleotide sequence identity with the PAO1 genome were included in the table. ID, identity; NSH, no significant hits.

 
FHA-like genes in P. aeruginosa

Although not unique to the LES, the previously identified subtracted sequence PSA shared similarity with the C-terminal sequence of Neisseria meningitidis FhaB, a putative adhesin with similarity to filamentous haemagglutinin (FHA) (Parsons et al., 2002), and was therefore potentially virulence related. Because the PSA sequence matched strain PAO1 downstream, we extended only upstream to a total of 2751 bp. Analysis of this extended region identified sequence PSA as a replacement sequence for the C terminus of the strain PAO1 ORF PA2462, encoding an FHA-like putative adhesion-related/haemagglutinin protein. FHA is a major virulence factor involved in the adherence of Bordetella species to epithelial cell surfaces (Locht et al., 1993). In conducting a web-based search of the strain PAO1 genome sequence database, Croft et al. (2000) identified six FHA-like genes. These have been assigned ORF numbers PA0041, PA0690, PA2462, PA4082, PA4541 and PA4625 at the genome database web site (http://www.pseudomonas.com). There is a striking similarity between PA0041 and PA2462, which share an identical sequence over most of their length, suggesting that this pair arose as a result of gene duplication (Croft et al., 2000). We carried out database searches using the C-terminal 100 amino acids from ORFPA0041 and ORF PA2462 from the genome-sequenced strains PAO1 and PA14 (available from http://www.ncbi.nlm.nih.gov) and found a different best match for each of these sequences and the LES PA2462 sequence, indicating that C-terminal polymorphisms in these proteins are not a rare phenomenon. Furthermore, there is a second variable region of ORF PA2462 further upstream (associated with PS9).

It has been demonstrated that the insertion of a transposon into the FHA-like genes PA0041, PA2462 and PA4625 results in reduced virulence in a rat model of chronic respiratory infection (Potvin et al., 2003), suggesting a role for each of these genes in pathogenicity. By extending SSH sequence PSA, we found that the LES equivalent of PA2462 contained an alternative C terminus as well as an alternative variable region further upstream. By screening data now available from the LES genome sequence project, we have been able not only to confirm this variation, but also to identify downstream of the PA2462 ORF a region of repeated FHA-like sequences, including an identical truncated C terminus equivalent to the PAO1 C terminus of ORF PA2462. In reporting the genome sequence of N. meningitidis serogroup A strain Z2491, Parkhill et al. (2000) refer to repeat mediated rearrangement of the 3' ends of a gene encoding a surface-exposed FHA-like protein. The sequence downstream of this gene contained complex repeated sequences also found within the gene. Sequencing of another N. meningitidis strain (Z4259, serogroup C) revealed a similar repeat structure, but with additional DNA inserted into the 3' sequence of NMA0688 at one of the repeats. This suggested that the 3' end of the gene can be altered by recombination with alternative 3' ends. Furthermore Klee et al. (2000) have reported that the C terminus of the FHA-like protein identified as similar to the PSA sequence (fhaB of N. meningitidis) is variable between strains. The authors hypothesize that repeated sequences could provide for variation in the C-terminal portion of the FhaB protein. They also report evidence that the fhaB gene is present in two copies in at least some strains of N. meningitidis.

The PA2462 peptide sequence shares significant similarity to Pseudomonas putida KT2440 ORFs PP0168 and PP1449 (Nelson et al., 2002). PP1449 (1508 amino acids) is the better match, and is also identified when the KT2440 genome is interrogated with PA0041 (E value of approximately 1x10–46). PP0168 is the largest gene (8682 amino acids) in the KT2440 genome and has the most unusual sequence (Weinel et al., 2002). The protein is rich in asparagine, valine and threonine, but contains no cysteine and is low in arginine. It contains two large threonine-rich repeats: the N-terminal repeat (nine units, each 100 amino acids long) and the C-terminal repeat (29 units, each 219 amino acids long). Although it has much in common with the P. aeruginosa genome, the only virulence-related genes that the genome of the avirulent P. putida KT2440 contains encode putative or confirmed adhesion proteins. Both PP0168 and PP1449 share homology with adhesin genes of enteropathogens and encode adhesins that are essential for seed colonization (Espinosa-Urgel et al., 2000; Nelson et al., 2002).

Thus, FHA-like proteins such as PA2462 may contribute to adhesion and colonization of disparate hosts, whether seed or human, and contain repeat sequences in the C terminus and downstream of the ORF with a probable role in mediating recombination. The biological function of such variations remains unknown, but since there may be a role for such proteins in the colonization of CF patients, further study is certainly merited.

LES subtracted library

Subtraction of the genome of strain PAO1 from that of isolate LES400 produced a library of clones, 106 of which were subjected to plasmid extraction and sequencing. Following the removal of duplicates and non-Tester-specific sequences, the subtraction added 78 sequences to the 14 obtained in a previous study (Parsons et al., 2002). The combined subtracted sequences are summarized in Table 3Go. Fifteen of the sequences shared similarity with mobile genetic elements, including bacteriophages D3 and D3112, both of which have been reported previously in P. aeruginosa (Cavenagh & Miller, 1986; Wang et al., 2004). A further six subtracted sequences were associated with transposition, recombination or DNA modification. Amongst the known variable genes matching subtracted sequences were several related to siderophores. We have reported previously that the LES has a type III pyoverdine receptor (Parsons et al., 2002). The SSH identified sequences related to the synthesis of both type III pyoverdine and the corresponding receptor (Smith et al., 2005). In addition, the LES carries genes for serotype O6. Four of the subtracted sequences shared similarity with serotype-related genes. Whilst four subtracted sequences indicated the presence of the known P. aeruginosa genomic islands PAGI-1 (Liang et al., 2001) and PAGI-2 (Larbig et al., 2002), a further five sequences shared similarity with four linked genes from Clostridium thermocellum ATCC 27405, suggesting that the LES may contain a low-G+C-content genomic island related to a gene cluster in this Gram-positive bacterium (Table 3Go). The subtraction also identified variations in the pilABC cluster. Such variations between strains of P. aeruginosa have been reported previously (Choi et al., 2002; Kus et al., 2004).

As well as the gene related to mercury resistance associated with PS21, the subtraction identified a putative gene involved in silver resistance. Three subtracted sequences shared similarity with proteins that have roles in the production of polyketides (Table 3Go). Two of these sequences matched a regulatory protein (PltR) involved in the synthesis of pyoluteorin, which has antifungal activities (Bender et al., 1999). BLASTX searches for 38 % of the LES subtracted sequences revealed either no significant matches or matches with hypothetical proteins of no known function.

Preliminary searches of the LES genome using SSH sequences

Preliminary searches of the LES genome sequence using BLASTN identified all but two of the SSH sequences. Interestingly, there was no BLASTN match in the LES genome (99.98 % theoretical coverage) for either LESC4 or LESC5, which match adjacent genes from bacteriophage D3112, suggesting that this bacteriophage may be present in isolate LES400 but missing from the genome-sequenced isolate (LESB58). Notably, many of the SSH sequences were found on common contigs containing putative genomic islands. A single contig contained, in order, the subtracted sequences LESC6, LESH12, PS54, LESF10, LESG7, LESE5, PS3, LESF1, LESB11, LESE3, LES11, LESF12, PS1, PS12, LESD8, LESB7 and LES4 (cluster 1). Further analysis indicated that sequence LESC6 is located at one edge of a putative genomic island incorporating all of the other SSH sequences with the exception of LES4, which lies beyond the putative island. The diagnostic probe (PS21) appears to lie in a cargo region of the previously identified island PAGI-2 (Klockgether et al., 2004; Larbig et al., 2002) that also contains LESB9, the putative silver-efflux-related sequence (cluster 2). Twelve of the SSH sequences (in order: LESH1, LESE4, LESB4, LESD11, LESG2, LESF9, LESD7, PS32, LES5, LESA8, LESE6 and LESB2) were clustered on a different contig within a second large putative island containing a number of genes related to C. thermocellum (cluster 3). There were three separate contigs containing multiple SSH sequences, some of which were bacteriophage related. One contained, in order, LES1, LESA9, LESC1, LESB6, LES6 and LESG5 (cluster 4); a second contained, in order, LESA11, LESH3, LESG11, LESE2, LESG3, LESA2, LESC11, LESC10, LESH5, LESA12 and LESF3 (cluster 5); and a third contained, in order, LESC3, LESE12, LESE7, LESF8, LESF6 and LESG9 (cluster 6). There were also several other contigs containing more than one SSH sequence. Not surprisingly, one of these linked the type III pyoverdine-synthesis-related sequences LESH4 and LES8.

Distribution of subtracted sequences

The distribution of 25 LES sequences amongst a panel of strains was assessed by PCR amplification assays using oligonucleotide primers designed from subtracted sequences (Table 4Go). The sequences selected included multiple representatives for each of the six major clusters identified by preliminary analysis of the genome sequence, sequence LESD9 (which shared a contig with LESB5, PS15, LESG10 and PS2), sequence LESB3 (which shared a contig with LESH11), and the type III pyoverdine-synthesis-related sequences LESH4 and LES8, and LESA3 (which shared a contig with LESA1).


View this table:
[in this window]
[in a new window]
 
Table 4. Distribution of subtracted sequences based on PCR amplification assays

1, LESC6; 2, LESH12; 3, LESG7; 4, LESF1; 5, LESB7; 6, LES4; 7, LESB9; 8, PS21; 9, LESE4; 10, LESD11; 11, LESF9; 12, LESE6; 13, LES1; 14, LESA9, 15, LES6; 16, LESA11; 17, LESG11; 18, LESH5; 19, LESE7; 20, LESF8; 21, LESG9; 22, LESD9; 23, LESB3; 24, LESH4; 25, LES8; 26, LESA3. N, not determined.

 
The distribution of sequences from cluster 1 confirmed that the putative genomic island was only present in LES isolates, but was completely missing from three LES isolates. LES4 is beyond the putative island and has a radically different distribution from the other SSH sequences on this contig (Table 4Go). All of the SSH sequences, including PS54, PS3, PS1 and PS12 from our previous study (Parsons et al., 2002), were absent from LES isolates 109 (isolated in Liverpool), 8995 (isolated in Sheffield, UK) and 10333 (isolated in Nottingham, UK). The putative island is flanked by equivalents to strain PAO1 ORFs PA0831 and PA0832.

Cluster 2, including PS21 and the silver–efflux-pump-related SSH sequence LESB9, was present in all LES isolates. All four PS21 false-positive strains were also PCR positive for LESB9, confirming the linkage of these two sequences. All SSH sequences tested from cluster 3 were PCR positive for all LES isolates but PCR negative for all other genetically characterized isolates (Table 4Go). Further PCR assays for sequences LESE4 and LESF9 were used to screen the uncharacterized non-LES CF isolates from Liverpool and from Clatterbridge Hospital. Three isolates (CH31, CH47 and 49278) were PCR positive for LESE4, and two of these isolates, CH47 and 49278, were also PCR positive for LESF9. All other PS21-negative isolates were PCR negative for each of these sequences. PFGE typing of isolates CH31, CH47 and 49278 confirmed that these did not match the LES pulsotype (data not shown).

The PCR-based distribution profiles for the three cluster 4 sequences were similar but not identical, and indicated some instability. Two LES isolates were PCR negative for all three sequences. Two of the three cluster 5 sequences (LESA11 and LESG11) shared identical distributions and were stable amongst LES and Midlands1 isolates. The third sequence tested from cluster 5 (LESH5) was greater than 50 kb away from the other two. Only LES isolates were PCR positive for this sequence. The three cluster 6 SSH sequences shared nearly identical distributions and were detected in all LES isolates. The other sequences screened were present in both LES and Midlands1 isolates. The Manchester epidemic strain isolates were PCR positive for only one of the sequences (LESA3, matching a putative siderophore receptor) tested (Table 4Go).

PCR-based identification of the LES

We have reported previously that the LES strain carries approximately 95 % of the ORFs present in strain PAO1 and that estimations based on PFGE indicate that the LES genome is no bigger than that of PAO1 (Salunkhe et al., 2005). In our previous study (Parsons et al., 2002), we identified 14 LES sequences subtracted from strain PAO1, including five (PS1, PS3, PS12, PS21 and PS54) that were LES specific. All of these, except PS21, were absent from one of the LES isolates screened (isolate 109). After considerably expanding the SSH database and conducting preliminary searches of the LESB58 genome sequence, it is clear that sequences PS1, PS3 and PS54, along with 13 other SSH sequences, are part of an LES-specific island that is associated with some instability. Thus, although we have never found this island in strains other than LES, any test for the LES based on this island may be prone to false negatives. In contrast, PS21, part of a merA gene located in an apparent cargo region of PAGI-2, is stable in the LES, but occurs rarely in other P. aeruginosa strains, making tests based on PS21 theoretically susceptible to rare false positives. Sequence LESF9 forms part of a putative genomic island present in all LES isolates but is, like PS21, occasionally also found in non-LES isolates. In the absence of a definitive LES-specific PCR assay that is positive for all LES isolates tested, we suggest a strategy using a combination of PCR assays for the detection of PS21 and LESF9. Since PS21 has proved to be an effective tool, especially in a setting where LES is widespread (Panagea et al., 2003; our unpublished data), we would propose the continuation of this test. For clinicians and patients alike, it is important that all LES isolates give a positive result. In order to achieve this, in the light of the instability of the LES genome, we may have to accept the possibility of rare false positives. However, if a combination of PCR assays for PS21 and LESF9 is used, then at least with our collection of isolates, only LES isolates are PCR positive for both of these sequences. We would suggest that any isolates that are PCR positive for just one of these sequences should be further tested using a different typing method, such as PFGE or RAPD.

The LES mobilome

The SSH data indicated that bacteriophage DNA is likely to make a significant contribution to the accessory genome of the LES. D3 is a lysogenic bacteriophage with a genome of 56.4 kb (Kropinski, 2000) (accession no. AF165214) implicated previously in serotype conversion (Newton et al., 2001) and transduction (Cavenagh & Miller, 1986) in P. aeruginosa. SSH sequences matching widely separated regions of the D3 sequence indicate the possible presence of this bacteriophage genome within the LES. D3112 is a transposable Mu-like bacteriophage with a genome of 37.6 kb (Wang et al., 2004). We identified LES sequences matching neighbouring genes within the D3112 genome, but we have no further indication concerning the extent of the D3112 DNA within the genome of the LES. Interestingly, these two sequences appear to be missing from the LES isolate chosen for genome sequencing, suggesting either that the bacteriophage has been acquired by isolate LES400 or that it has been lost by isolate LESB58. In addition, the bacteriophage-related cluster 4 was absent from some LES isolates. SSH also indicated that the LES contains a putative tail-fibre protein from another bacteriophage reported elsewhere in P. aeruginosa (Nakayama et al., 2000). The presence of several other subtracted sequences with matches sharing lower identities with bacteriophage-related proteins, many clustered on to one of three contigs, suggests that there may be additional whole (or fragments of) bacteriophage genomes within the LES. The details will become clear when the ongoing genome sequence project is further advanced.


    ACKNOWLEDGEMENTS
 
We would like to thank Ty Pitt and Fiona Scott for providing strains. We are also grateful to Julian Parkhill and colleagues at the Pathogen Sequencing Unit of the Wellcome Trust Sanger Unit, and Bob Hancock, Fiona Brinkman and colleagues from the Pseudomonas Genome Project, for their excellent work in the LES and PAO1 genome sequence projects. This work was funded by the UK Cystic Fibrosis Trust.


    REFERENCES
 TOP
 INTRODUCTION
 METHODS
 RESULTS AND DISCUSSION
 REFERENCES
 
Al Aloul, M., Crawley, J., Winstanley, C., Hart, C. A., Ledson, M. J. & Walshaw, M. J. (2004). Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients. Thorax 59, 334–336.[Abstract/Free Full Text]

Armstrong, D., Bell, S., Robinson, M. & 8 other authors (2003). Evidence for spread of a clonal strain of Pseudomonas aeruginosa among cystic fibrosis clinics. J Clin Microbiol 41, 2266–2267.[Free Full Text]

Bender, C., Rangaswamy, V. & Loper, J. (1999). Polyketide production by plant-associated pseudomonads. Annu Rev Phytopathol 37, 175–196.[CrossRef][Medline]

Cavenagh, M. M. & Miller, R. V. (1986). Specialized transduction of Pseudomonas aeruginosa PAO by bacteriophage D3. J Bacteriol 165, 448–452.[Abstract/Free Full Text]

Chambers, D., Scott, F., Bangur, R. & 7 other authors (2005). Factors associated with infection by Pseudomonas aeruginosa in adult cystic fibrosis. Eur Respir J 26, 651–656.[Abstract/Free Full Text]

Cheng, K., Smyth, R. L., Govan, J. R., Doherty, C., Winstanley, C., Denning, N., Heaf, D. P., van Saene, H. & Hart, C. A. (1996). Spread of beta-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic. Lancet 348, 639–642.[CrossRef][Medline]

Choi, J. Y., Sifri, C. D., Goumnerov, B. C., Rahme, L. G., Ausubel, F. M. & Calderwood, S. B. (2002). Identification of virulence genes in a pathogenic strain of Pseudomonas aeruginosa by representational difference analysis. J Bacteriol 184, 952–961.[Abstract/Free Full Text]

Croft, L., Beatson, S. A., Whitchurch, C. B., Huang, B., Blakeley, R. L. & Mattick, J. S. (2000). An interactive web-based Pseudomonas aeruginosa genome database: discovery of new genes, pathways and structures. Microbiology 146, 2351–2364.[Abstract/Free Full Text]

Edenborough, F. P., Stone, H. R., Kelly, S. J., Zadik, P., Doherty, C. J. & Govan, J. R. (2004). Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation. J Cyst Fibros 3, 37–44.[Medline]

Ernst, R. K., D'Argenio, D. A., Ichikawa, J. K. & 12 other authors (2003). Genome mosaicism is conserved but not unique in Pseudomonas aeruginosa isolates from the airways of young children with cystic fibrosis. Environ Microbiol 5, 1341–1349.[CrossRef][Medline]

Espinosa-Urgel, M., Salido, A. & Ramos, J. L. (2000). Genetic analysis of functions involved in adhesion of Pseudomonas putida to seeds. J Bacteriol 182, 2363–2369.[Abstract/Free Full Text]

Jones, A. M., Govan, J. R., Doherty, C. J., Dodd, M. E., Isalska, B. J., Stanbridge, T. N. & Webb, A. K. (2001). Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358, 557–558.[CrossRef][Medline]

Klee, S. R., Nassif, X., Kusecek, B., Merker, P., Beretti, J. L., Achtman, M. & Tinsley, C. R. (2000). Molecular and biological analysis of eight genetic islands that distinguish Neisseria meningitidis from the closely related pathogen Neisseria gonorrhoeae. Infect Immun 68, 2082–2095.[Abstract/Free Full Text]

Klockgether, J., Reva, O., Larbig, K. & Tümmler, B. (2004). Sequence analysis of the mobile genome island pKLC102 of Pseudomonas aeruginosa C. J Bacteriol 186, 518–534.[Abstract/Free Full Text]

Kropinski, A. M. (2000). Sequence of the genome of the temperate, serotype-converting, Pseudomonas aeruginosa bacteriophage D3. J Bacteriol 182, 6066–6074.[Abstract/Free Full Text]

Kus, J. V., Tullis, E., Cvitkovitch, D. G. & Burrows, L. L. (2004). Significant differences in type IV pilin allele distribution among Pseudomonas aeruginosa isolates from cystic fibrosis (CF) versus non-CF patients. Microbiology 150, 1315–1326.[Abstract/Free Full Text]

Larbig, K. D., Christmann, A., Johann, A., Klockgether, J., Hartsch, T., Merkl, R., Wiehlmann, L., Fritz, H. J. & Tümmler, B. (2002). Gene islands integrated into tRNAGly genes confer genome diversity on a Pseudomonas aeruginosa clone. J Bacteriol 184, 6665–6680.[Abstract/Free Full Text]

Lewis, D. A., Jones, A., Parkhill, J., Speert, D. P., Govan, J. R., Lipuma, J. J., Lory, S., Webb, A. K. & Mahenthiralingam, E. (2005). Identification of DNA markers for a transmissible Pseudomonas aeruginosa cystic fibrosis strain. Am J Respir Cell Mol Biol 33, 56–64.[Abstract/Free Full Text]

Liang, X., Pham, X. Q., Olson, M. V. & Lory, S. (2001). Identification of a genomic island present in the majority of pathogenic isolates of Pseudomonas aeruginosa. J Bacteriol 183, 843–853.[Abstract/Free Full Text]

Locht, C., Bertin, P., Menozzi, F. D. & Renauld, G. (1993). The filamentous haemagglutinin, a multifaceted adhesion produced by virulent Bordetella spp. Mol Microbiol 9, 653–660.[CrossRef][Medline]

McCallum, S. J., Corkill, J., Gallagher, M., Ledson, M. J., Hart, C. A. & Walshaw, M. J. (2001). Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P. aeruginosa. Lancet 358, 558–560.[CrossRef][Medline]

McCallum, S. J., Gallagher, M. J., Corkill, J. E., Hart, C. A., Ledson, M. J. & Walshaw, M. J. (2002). Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives. Thorax 57, 559–560.[Abstract/Free Full Text]

Nakayama, K., Takashima, K., Ishihara, H. & 7 other authors (2000). The R-type pyocin of Pseudomonas aeruginosa is related to P2 phage, and the F-type is related to lambda phage. Mol Microbiol 38, 213–231.[CrossRef][Medline]

Nelson, K. E., Weinel, C., Paulsen, I. T. & 40 other authors (2002). Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol 4, 799–808.[CrossRef][Medline]

Newton, G. J., Daniels, C., Burrows, L. L., Kropinski, A. M., Clarke, A. J. & Lam, J. S. (2001). Three-component-mediated serotype conversion in Pseudomonas aeruginosa by bacteriophage D3. Mol Microbiol 39, 1237–1247.[CrossRef][Medline]

O'Carroll, M. R., Syrmis, M. W., Wainwright, C. E., Greer, R. M., Mitchell, P., Coulter, C., Sloots, T. P., Nissen, M. D. & Bell, S. C. (2004). Clonal strains of Pseudomonas aeruginosa in paediatric and adult cystic fibrosis units. Eur Respir J 24, 101–106.[Abstract/Free Full Text]

Panagea, S., Winstanley, C., Parsons, Y. N., Walshaw, M. J., Ledson, M. J. & Hart, C. A. (2003). PCR-based detection of a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. Mol Diagn 7, 195–200.[CrossRef][Medline]

Parkhill, J., Achtman, M., James, K. D. & 25 other authors (2000). Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature 404, 502–506.[CrossRef][Medline]

Parsons, Y. N., Panagea, S., Smart, C. H. M., Walshaw, M. J., Hart, C. A. & Winstanley, C. (2002). Use of subtractive hybridization to identify a diagnostic probe for a cystic fibrosis epidemic strain of Pseudomonas aeruginosa. J Clin Microbiol 40, 4607–4611.[Abstract/Free Full Text]

Potvin, E., Lehoux, D. E., Kukavica-Ibrulj, I., Richard, K. L., Sanschagrin, F., Lau, G. W. & Levesque, R. C. (2003). In vivo functional genomics of Pseudomonas aeruginosa for high-throughput screening of new virulence factors and antibacterial targets. Environ Microbiol 5, 1294–1308.[CrossRef][Medline]

Rahme, L. G., Stevens, E. J., Wolfort, S. F., Shao, J., Tompkins, R. G. & Ausubel, F. M. (1995). Common virulence factors for bacterial pathogenicity in plants and animals. Science 268, 1899–1902.[Abstract/Free Full Text]

Römling, U., Wingender, J., Muller, H. & Tümmler, B. (1994). A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60, 1734–1738.[Abstract/Free Full Text]

Salunkhe, P., Smart, C. H. M., Morgan, J. A. W., Panagea, S., Walshaw, M. J., Hart, C. A., Geffers, R., Tümmler, B. & Winstanley, C. (2005). A cystic fibrosis epidemic strain of Pseudomonas aeruginosa displays enhanced virulence and antimicrobial resistance. J Bacteriol 187, 4908–4920.[Abstract/Free Full Text]

Scott, F. W. & Pitt, T. L. (2004). Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales. J Med Microbiol 53, 609–615.[Abstract/Free Full Text]

Smith, E. E., Sims, E. H., Spencer, D. H., Kaul, R. & Olson, M. V. (2005). Evidence for diversifying selection at the pyoverdine locus of Pseudomonas aeruginosa. J Bacteriol 187, 2138–2147.[Abstract/Free Full Text]

Spencer, D. H., Kas, A., Smith, E. E., Raymond, C. K., Sims, E. H., Hastings, M., Burns, J. L., Kaul, R. & Olson, M. V. (2003). Whole-genome sequence variation among multiple isolates of Pseudomonas aeruginosa. J Bacteriol 185, 1316–1325.[Abstract/Free Full Text]

Stover, C. K., Pham, X. Q., Erwin, A. L. & 28 other authors (2000). Complete genome sequence of Pseudomonas aeruginosa PA01, an opportunistic pathogen. Nature 406, 959–964.[CrossRef][Medline]

Tenover, F. C., Arbeit, R. D., Goering, R. V., Mickelsen, P. A., Murray, B. E., Persing, D. H. & Swaminathan, B. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33, 2233–2239.[Medline]

Wang, P. W., Chu, L. & Guttman, D. S. (2004). Complete sequence and evolutionary genomic analysis of the Pseudomonas aeruginosa transposable bacteriophage D3112. J Bacteriol 186, 400–410.[Abstract/Free Full Text]

Weinel, C., Nelson, K. E. & Tümmler, B. (2002). Global features of the Pseudomonas putida KT2440 genome sequence. Environ Microbiol 4, 809–818.[CrossRef][Medline]

Winstanley, C. (2002). Spot the difference: applications of subtractive hybridization to the study of bacterial pathogens. J Med Microbiol 51, 459–467.[Abstract/Free Full Text]

Winstanley, C. & Hart, C. A. (2000). Presence of type III secretion genes in Burkholderia pseudomallei correlates with Ara phenotypes. J Clin Microbiol 38, 883–885.[Abstract/Free Full Text]

Wolfgang, M. C., Kulasekara, B. R., Liang, X., Boyd, D., Wu, K., Yang, Q., Miyada, C. G. & Lory, S. (2003). Conservation of genome content and virulence determinants among clinical and environmental isolates of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100, 8484–8489.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Genome ResHome page
C. Winstanley, M. G.I. Langille, J. L. Fothergill, I. Kukavica-Ibrulj, C. Paradis-Bleau, F. Sanschagrin, N. R. Thomson, G. L. Winsor, M. A. Quail, N. Lennard, et al.
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa
Genome Res., January 1, 2009; 19(1): 12 - 23.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
K Mohan, J L Fothergill, J Storrar, M J Ledson, C Winstanley, and M J Walshaw
Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat
Thorax, September 1, 2008; 63(9): 839 - 840.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
I. Kukavica-Ibrulj, A. Bragonzi, M. Paroni, C. Winstanley, F. Sanschagrin, G. A. O'Toole, and R. C. Levesque
In Vivo Growth of Pseudomonas aeruginosa Strains PAO1 and PA14 and the Hypervirulent Strain LESB58 in a Rat Model of Chronic Lung Infection
J. Bacteriol., April 15, 2008; 190(8): 2804 - 2813.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
T. Tralau, S. Vuilleumier, C. Thibault, B. J. Campbell, C. A. Hart, and M. A. Kertesz
Transcriptomic Analysis of the Sulfate Starvation Response of Pseudomonas aeruginosa
J. Bacteriol., October 1, 2007; 189(19): 6743 - 6750.
[Abstract] [Full Text] [PDF]


Home page
J Med MicrobiolHome page
C. H. M. Smart, F. W. Scott, E. A. Wright, M. J. Walshaw, C. A. Hart, T. L. Pitt, and C. Winstanley
Development of a diagnostic test for the Midlands 1 cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1085 - 1091.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.
Agricola
Right arrow Articles by Smart, C. H. M.
Right arrow Articles by Winstanley, C.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL J MED MICROBIOL MICROBIOLOGY J GEN VIROL ALL SGM JOURNALS